Evidence map›Paper›PMID 32417972›Full record

ArticleJournal of molecular modeling2020

Theoretical study of rhodium(III)-catalyzed synthesis of benzoxepine and coumarin.

Xinghui Zhang, Xi Wu, Shanshan Li, Haixiong Shi, Yun Lei, Teng Niu

Abstract read
PubMed Publisher
In one paragraph

Article in Journal of molecular modeling, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Xinghui ZhangSchool of Chemical Engineering, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China. zhxh135@163.com.
Xi WuSchool of Foreign Languages, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China.
Shanshan LiSchool of Chemical Engineering, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China.
Haixiong ShiSchool of Chemical Engineering, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China.
Yun LeiSchool of Chemical Engineering, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China.
Teng NiuSchool of Chemical Engineering, Lanzhou University of Arts and Science, Lanzhou, 730010, Gansu, People's Republic of China.

Funding

the Outstanding Youth Research Program of Lanzhou University of Arts and Sciences 2018JCQN008
6 · The paper itself

Abstract

The mechanisms of the rhodium-catalyzed cycloaddition of 2-vinylphenol with diphenylacetylene and carbon monoxide have been studied using density functional theory calculations at the B3LYP/6-31G (d, p) (Lanl2dz for Rh) level of theory. The SMD solvation model was used in MeCN solvents at M06-2X/6-311 ++ G (d, p) (Lanl2dz (f) for Rh) levels using a single-point calculation to consider the solvent effect. The calculation results show that there are two competitive reaction pathways for the cycloaddition reaction of rhodium-catalyzed synthesis of benzohexine and coumarin. Starting from the precursor reaction complex, the reaction channel is more favorable for the carbon atoms of diphenylacetylene and carbon monoxide to attack the Rh-C bond (the barriers of 9.88 and 10.01 kcal/mol) rather than attack the Rh-O bond (the barriers of 15.37 and 30.17 kcal/mol), and carbon monoxide in two different reaction channels has a greater energy difference than diphenylacetylene. The results show that the computational study of the rhodium-catalyzed cycloaddition reaction has a high catalytic activity consistent with the high yield of the experiment of Gulías et al.

Indexed as

Models, ChemicalAcetyleneBenzoxepinsCarbon MonoxideCatalysisComputational ChemistryCoumarinsRhodiumAcetyleneBenzoxepinsbiphenylacetyleneCarbon MonoxidecoumarinCoumarinsRhodium2-vinylphenolCycloadditionDiphenylacetyleneRhodium(III)-catalyzed

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.